• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性胸腺瘤手术治疗与非手术治疗的荟萃分析。

A meta-analysis of surgical versus nonsurgical management of recurrent thymoma.

作者信息

Hamaji Masatsugu, Ali Syed Osman, Burt Bryan M

机构信息

Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan.

Division of Cardiothoracic Surgery, Altru Hospital, Grand Forks, North Dakota.

出版信息

Ann Thorac Surg. 2014 Aug;98(2):748-55. doi: 10.1016/j.athoracsur.2014.04.028. Epub 2014 Jun 28.

DOI:10.1016/j.athoracsur.2014.04.028
PMID:24980604
Abstract

This meta-analysis was designed to determine the effect of surgical and nonsurgical approaches on 5-year and 10-year overall survival (OS) in patients with recurrent thymoma. PubMed, Scopus, and the Journal of Japanese Association for Chest Surgery were queried, and 11 studies were eligible. Our meta-analysis using a random-effect model revealed significant differences in the rates of 5- and 10-year OS after thymectomy and in 5-year OS after recurrence, favoring surgically managed patients. Surgical resection may be associated with improved long-term survival and should be considered for patients with recurrent thymoma.

摘要

本荟萃分析旨在确定手术和非手术方法对复发性胸腺瘤患者5年和10年总生存率(OS)的影响。检索了PubMed、Scopus和《日本胸部外科学会杂志》,共有11项研究符合条件。我们使用随机效应模型进行的荟萃分析显示,胸腺切除术后5年和10年总生存率以及复发后5年总生存率存在显著差异,手术治疗的患者更具优势。手术切除可能与长期生存率提高相关,复发性胸腺瘤患者应考虑手术治疗。

相似文献

1
A meta-analysis of surgical versus nonsurgical management of recurrent thymoma.复发性胸腺瘤手术治疗与非手术治疗的荟萃分析。
Ann Thorac Surg. 2014 Aug;98(2):748-55. doi: 10.1016/j.athoracsur.2014.04.028. Epub 2014 Jun 28.
2
Thoracoscopic thymectomy versus open thymectomy for the treatment of thymoma: A meta-analysis.胸腔镜胸腺切除术与开放性胸腺切除术治疗胸腺瘤的Meta分析
Eur J Surg Oncol. 2016 Nov;42(11):1720-1728. doi: 10.1016/j.ejso.2016.03.029. Epub 2016 Apr 12.
3
A meta-analysis of debulking surgery versus surgical biopsy for unresectable thymoma.对不可切除胸腺瘤进行减瘤手术与手术活检的荟萃分析。
Eur J Cardiothorac Surg. 2015 Apr;47(4):602-7. doi: 10.1093/ejcts/ezu277. Epub 2014 Jul 11.
4
Video-assisted thoracoscopic surgical thymectomy to treat early thymoma: a comparison with the conventional transsternal approach.电视辅助胸腔镜手术治疗早期胸腺瘤:与传统经胸骨入路的比较。
Ann Surg Oncol. 2014 Jan;21(1):322-8. doi: 10.1245/s10434-013-3228-7. Epub 2013 Aug 28.
5
Clinical outcomes and prognosis of recurrent thymoma management.复发性胸腺瘤的临床转归和预后。
J Thorac Oncol. 2012 Aug;7(8):1304-14. doi: 10.1097/JTO.0b013e3182598a91.
6
[Thymoma with long-term survival treated by polysurgery; report of a case].
Kyobu Geka. 2009 Aug;62(9):839-41.
7
Successful long-term outcome in locally advanced Masaoka IVA thymoma with induction chemotherapy followed by complete resection and adjuvant radiotherapy.局部晚期Masaoka IVA期胸腺瘤患者,先进行诱导化疗,然后完整切除并接受辅助放疗,获得成功的长期预后。
Ann Thorac Surg. 2008 Nov;86(5):1725; author reply 1725. doi: 10.1016/j.athoracsur.2008.05.047.
8
The role of adjuvant radiation therapy for resected stage III thymoma: a population-based study.术后辅助放疗在 III 期胸腺瘤中的作用:一项基于人群的研究。
Ann Thorac Surg. 2012 Jun;93(6):1822-8; discussion 1828-9. doi: 10.1016/j.athoracsur.2012.03.004. Epub 2012 May 1.
9
Thymic carcinoma: outcomes after surgical resection.胸腺癌:手术切除后的结果。
Ann Thorac Surg. 2012 May;93(5):1668-72; discussion 1672-3. doi: 10.1016/j.athoracsur.2012.01.014. Epub 2012 Mar 14.
10
Factors predicting recurrence and postrecurrence survival in completely resected thymic carcinoma.完全切除的胸腺癌的复发和复发后生存的预测因素。
Ann Thorac Surg. 2014 Apr;97(4):1169-75. doi: 10.1016/j.athoracsur.2013.12.024. Epub 2014 Feb 12.

引用本文的文献

1
Surgical Expert Consensus on Clinical Management of Advanced Thymoma and Thymic Carcinoma: A Beijing-Tianjin-Hebei Collaborative Initiative.《晚期胸腺瘤和胸腺癌临床管理外科专家共识:京津冀协同倡议》
Thorac Cancer. 2025 Jul;16(14):e70133. doi: 10.1111/1759-7714.70133.
2
Robotic thymectomy for large thymomas: a multicenter study.大型胸腺瘤的机器人胸腺切除术:一项多中心研究。
J Robot Surg. 2025 Jun 19;19(1):307. doi: 10.1007/s11701-025-02476-1.
3
Updated outcomes of surgical treatment for recurrent thymic tumour: a report from the Japanese nationwide database.
复发性胸腺瘤外科治疗的最新结果:来自日本全国数据库的报告
Interdiscip Cardiovasc Thorac Surg. 2024 Jun 5;38(6). doi: 10.1093/icvts/ivae064.
4
Update on thymic epithelial tumors: a narrative review.胸腺上皮肿瘤的最新进展:一篇叙述性综述
Mediastinum. 2024 Apr 26;8:33. doi: 10.21037/med-23-47. eCollection 2024.
5
Salvage surgery for recurrent transdiaphragmatic thymoma in a patient not eligible for chemotherapy.
J Surg Case Rep. 2024 May 5;2024(5):rjae288. doi: 10.1093/jscr/rjae288. eCollection 2024 May.
6
Prognostic factors and role of postoperative radiotherapy in surgically resected thymomas.手术切除胸腺瘤的预后因素及术后放疗的作用
JTCVS Open. 2023 Mar 3;14:561-580. doi: 10.1016/j.xjon.2023.02.013. eCollection 2023 Jun.
7
Developing and validating a nomogram to predict myasthenia gravis exacerbation in patients with postoperative thymoma recurrence.开发并验证一种列线图以预测术后胸腺瘤复发患者的重症肌无力加重情况。
Gland Surg. 2022 Oct;11(10):1712-1721. doi: 10.21037/gs-22-549.
8
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis.T-DM1 治疗曲妥珠单抗-帕妥珠单抗预处理的 HER2 阳性转移性乳腺癌患者的疗效:一项荟萃分析。
BMC Cancer. 2022 Jun 7;22(1):623. doi: 10.1186/s12885-022-09556-7.
9
Treatment options for stage IVA thymic malignancies.IVA期胸腺恶性肿瘤的治疗选择。
Mediastinum. 2019 Sep 26;3:39. doi: 10.21037/med.2019.09.02. eCollection 2019.
10
Diagnostic and prognostic value of FDG PET-CT in patients with suspected recurrent thymic epithelial tumors.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在疑似复发性胸腺瘤患者中的诊断和预后价值。
Sci Rep. 2021 Oct 15;11(1):20521. doi: 10.1038/s41598-021-00003-4.